BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 33767707)

  • 1. Activation of Toll-Like Receptor 7 Signaling Pathway in Primary Sjögren's Syndrome-Associated Thrombocytopenia.
    Zhang S; Qu J; Wang L; Li M; Xu D; Zhao Y; Zhang F; Zeng X
    Front Immunol; 2021; 12():637659. PubMed ID: 33767707
    [No Abstract]   [Full Text] [Related]  

  • 2. Activation of TLR9-dependent p38MAPK pathway in the pathogenesis of primary Sjögren's syndrome in NOD/Ltj mouse.
    Shi H; Yu CQ; Xie LS; Wang ZJ; Zhang P; Zheng LY
    J Oral Pathol Med; 2014 Nov; 43(10):785-91. PubMed ID: 25065264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of Toll-like receptor 7 signaling in labial salivary glands of primary Sjögren's syndrome patients.
    Shimizu T; Nakamura H; Takatani A; Umeda M; Horai Y; Kurushima S; Michitsuji T; Nakashima Y; Kawakami A
    Clin Exp Immunol; 2019 Apr; 196(1):39-51. PubMed ID: 30446998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single Cell Based Phosphorylation Profiling Identifies Alterations in Toll-Like Receptor 7 and 9 Signaling in Patients With Primary Sjögren's Syndrome.
    Davies R; Sarkar I; Hammenfors D; Bergum B; Vogelsang P; Solberg SM; Gavasso S; Brun JG; Jonsson R; Appel S
    Front Immunol; 2019; 10():281. PubMed ID: 30846988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TLR7 agonism accelerates disease in a mouse model of primary Sjögren's syndrome and drives expansion of T-bet
    Punnanitinont A; Kasperek EM; Kiripolsky J; Zhu C; Miecznikowski JC; Kramer JM
    Front Immunol; 2022; 13():1034336. PubMed ID: 36591307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered phenotype and Stat1 expression in Toll-like receptor 7/8 stimulated monocyte-derived dendritic cells from patients with primary Sjögren's syndrome.
    Vogelsang P; Karlsen M; Brun JG; Jonsson R; Appel S
    Arthritis Res Ther; 2014 Aug; 16(4):R166. PubMed ID: 25113744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated expression of Toll-like receptor 7 and its correlation with clinical features in patients with primary Sjögren's syndrome.
    Yang H; Sun C; Wang X; Wang T; Xie C; Li Z
    Adv Rheumatol; 2024 Mar; 64(1):17. PubMed ID: 38439071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of Myd88-Dependent TLRs Mediates Local and Systemic Inflammation in a Mouse Model of Primary Sjögren's Syndrome.
    Kiripolsky J; Romano RA; Kasperek EM; Yu G; Kramer JM
    Front Immunol; 2019; 10():2963. PubMed ID: 31993047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of Toll-like receptors 7, 8, and 9 in primary Sjögren's syndrome.
    Zheng L; Zhang Z; Yu C; Yang C
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Jun; 109(6):844-50. PubMed ID: 20399690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contrasting expression pattern of RNA-sensing receptors TLR7, RIG-I and MDA5 in interferon-positive and interferon-negative patients with primary Sjögren's syndrome.
    Maria NI; Steenwijk EC; IJpma AS; van Helden-Meeuwsen CG; Vogelsang P; Beumer W; Brkic Z; van Daele PL; van Hagen PM; van der Spek PJ; Drexhage HA; Versnel MA
    Ann Rheum Dis; 2017 Apr; 76(4):721-730. PubMed ID: 27672125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of Toll-like receptor -7 and -9 in B cell subsets from patients with primary Sjögren's syndrome.
    Karlsen M; Hansen T; Nordal HH; Brun JG; Jonsson R; Appel S
    PLoS One; 2015; 10(3):e0120383. PubMed ID: 25790192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Transcriptomic Profile of Monocytes from Patients With Sjögren's Syndrome Is Associated With Inflammatory Parameters and Is Mimicked by Circulating Mediators.
    Lopes AP; Bekker CPJ; Hillen MR; Blokland SLM; Hinrichs AC; Pandit A; Kruize AA; Radstake TRDJ; van Roon JAG
    Front Immunol; 2021; 12():701656. PubMed ID: 34413853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TLR2 ligation induces the production of IL-23/IL-17 via IL-6, STAT3 and NF-kB pathway in patients with primary Sjogren's syndrome.
    Kwok SK; Cho ML; Her YM; Oh HJ; Park MK; Lee SY; Woo YJ; Ju JH; Park KS; Kim HY; Park SH
    Arthritis Res Ther; 2012 Mar; 14(2):R64. PubMed ID: 22417709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toll-Like Receptor 7 Is Required for Lacrimal Gland Autoimmunity and Type 1 Diabetes Development in Male Nonobese Diabetic Mice.
    Debreceni IL; Chimenti MS; Serreze DV; Geurts AM; Chen YG; Lieberman SM
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33322152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TLR-7 and -9 Stimulation of Peripheral Blood B Cells Indicate Altered TLR Signalling in Primary Sjögren's Syndrome Patients by Increased Secretion of Cytokines.
    Karlsen M; Jonsson R; Brun JG; Appel S; Hansen T
    Scand J Immunol; 2015 Dec; 82(6):523-31. PubMed ID: 26332048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-proliferating plasma cells detected in the salivary glands and bone marrow of autoimmune NOD.B10.H2b mice, a model for primary Sjögren's syndrome.
    Szyszko EA; Aqrawi LA; Jonsson R; Brokstad KA; Skarstein K
    Autoimmunity; 2016; 49(1):41-9. PubMed ID: 26324998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-36α axis is modulated in patients with primary Sjögren's syndrome.
    Ciccia F; Accardo-Palumbo A; Alessandro R; Alessandri C; Priori R; Guggino G; Raimondo S; Carubbi F; Valesini G; Giacomelli R; Rizzo A; Triolo G
    Clin Exp Immunol; 2015 Aug; 181(2):230-8. PubMed ID: 25902739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoantigen-specific B cells and plasma cells are prominent in areas of fatty infiltration in salivary glands of patients with primary Sjögren's syndrome.
    Skarstein K; Jensen JL; Galtung H; Jonsson R; Brokstad K; Aqrawi LA
    Autoimmunity; 2019; 52(7-8):242-250. PubMed ID: 31661985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TBK1: A key regulator and potential treatment target for interferon positive Sjögren's syndrome, systemic lupus erythematosus and systemic sclerosis.
    Bodewes ILA; Huijser E; van Helden-Meeuwsen CG; Tas L; Huizinga R; Dalm VASH; van Hagen PM; Groot N; Kamphuis S; van Daele PLA; Versnel MA
    J Autoimmun; 2018 Jul; 91():97-102. PubMed ID: 29673738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knockdown of RSAD2 attenuates B cell hyperactivity in patients with primary Sjögren's syndrome (pSS) via suppressing NF-κb signaling pathway.
    Zhu H; Zheng J; Zhou Y; Wu T; Zhu T
    Mol Cell Biochem; 2021 May; 476(5):2029-2037. PubMed ID: 33512636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.